Journal of Medicinal Chemistry p. 7396 - 7415 (2013)
Update date:2022-08-15
Topics:
Surivet, Jean-Philippe
Zumbrunn, Cornelia
Rueedi, Georg
Hubschwerlen, Christian
Bur, Daniel
Bruyère, Thierry
Locher, Hans
Ritz, Daniel
Keck, Wolfgang
Seiler, Peter
Kohl, Christopher
Gauvin, Jean-Christophe
Mirre, Azely
Kaegi, Verena
Dos Santos, Marina
Gaertner, Mika
Delers, Jonathan
Enderlin-Paput, Michel
Boehme, Maria
There is an urgent need for new antibacterial drugs that are effective against infections caused by multidrug-resistant pathogens. Novel nonfluoroquinolone inhibitors of bacterial type II topoisomerases (DNA gyrase and topoisomerase IV) have the potential
View MoreHangzhou Yanshan Chemical Co.,Ltd.
Contact:86-571- 87698076
Address:Room 1001, #1 Building, Zhongtian MCC, No.2 Youzhinong, Wenyi West Road, Xihu District, Hangzhou, China
Jiangsu Cale New Material Co.ltd
Contact:+86-515-88334667/88203550
Address:Zhongshan 3rd Road, Coastal Chemical Industry Park, Yancheng, Jiangsu, China
Shanghai AoBo Bio-Pharmaceutical Technology Co., Ltd.
Contact:+86-21-51320130-801, 816
Address:Room 601, No. 1011, Halei Road, Zhangjiang High-Tech Park, Pudong, Shanghai
Jinan Trio PharmaTech Co., Ltd
Contact:86-531-88811783;+(0)13153010282
Address:2766 Yingxiu Road, Jinan High-Tech Zone, China
Hubei Lansun Biochemical Pharmaceutical Co., Ltd
Contact:714-6395977
Address:No. 81 Pengcheng Avenue, economic and technological development zone, Huangshi City, Hubei Province,China
Doi:10.1016/j.tetlet.2006.02.043
(2006)Doi:10.1002/ejoc.201301657
(2014)Doi:10.3762/bjoc.12.86
(2016)Doi:10.1039/b515616e
(2006)Doi:10.1021/jo00178a036
(1984)Doi:10.1007/s11176-005-0266-2
(2005)